© The Author 2006. Published by Oxford University Press.
CORRESPONDENCE |
Re: Incidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United States
Correspondence to: Bhadrasain Vikram, MD, Clinical Radiation Oncology Branch, National Cancer Institute, 6130 Executive Blvd., Suite 6002, Rockville, MD 20892-7440 (e-mail: vikramb@mail.nih.gov).
| The first 10% of the full text of this article appears below. |
Miller et al. (1) found that among men with lower-risk prostate cancer, 55% may have been overtreated (most of them by radiation
Related Article in JNCI
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2006 98: 1134-1141.
J Natl Cancer Inst 2006 98: 1826.
This article has been cited by other articles:
![]() |
N. Soga, K. Arima, and Y. Sugimura Undetectable Level of Prostate Specific Antigen (PSA) Nadir Predicts PSA Biochemical Failure in Local Prostate Cancer with Delayed-combined Androgen Blockade Jpn. J. Clin. Oncol., September 1, 2008; 38(9): 617 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Kuderer, D. C. Dale, J. Crawford, and G. H. Lyman Impact of Primary Prophylaxis With Granulocyte Colony-Stimulating Factor on Febrile Neutropenia and Mortality in Adult Cancer Patients Receiving Chemotherapy: A Systematic Review J. Clin. Oncol., July 20, 2007; 25(21): 3158 - 3167. [Abstract] [Full Text] [PDF] |
||||

